Prenetics Global logo

Prenetics Global(NASDAQ) PRENW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-99%
5 Year-99%
1 Year-69%
1 Month-25%
$0.01
-10.19%
-0.00Today
Prenetics Global last closing stock price
MetricPriceDate
Last closeUSD 0.012026-10-13
Prenetics Global stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.26%USD 0.012026-10-02
1 month-24.99%USD 0.012026-09-04
3 month-44.71%USD 0.022026-07-15
Year to date-67.53%USD 0.032025-12-31
1 year-69.48%USD 0.032025-10-13
3 year-69.76%USD 0.032023-10-13
5 year-99.01%USD 0.982021-10-14
Since inception-98.98%USD 0.952021-07-19

Prenetics Global Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$142.56M

Net Income (TTM)

-$67.61M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.09 (Low)

Price

$0.01

Volume

12,144

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.04

Estimated Earnings Date

Nov 5, 2026

PRENW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prenetics Global

Prenetics Global Limited is an investment holding company specializing in diagnostics and genetic testing. The company offers innovative health solutions, including consumer genetic testing and rapid detection health monitoring systems.

Products and Services
  • CircleDNA, a comprehensive consumer genetic testing solution
  • Circle HealthPod, a rapid COVID-19 detection system
  • ColoClear, a non-invasive colorectal cancer screening test
Growth Outlook
  • Recent quarterly revenue reached $46.5 million, indicating strong demand
  • TTM gross profit margin stands at 62.6%, showcasing operational efficiency
  • Current ratio of 4.04 suggests robust liquidity position
Financial Highlights
  • Net income for Q2 2026 was -$8.98 million, reflecting ongoing investment in growth
  • Cash and short-term investments totaled $109.39 million, providing financial stability
  • Operating expenses for Q2 2026 were $52.12 million, driven by strategic marketing efforts
AI Generated • Oct 4, 2026

Industry

Healthcare Providers and Services

Headquarters

Hong Kong, HK

PRENW Financials

Key Financial Metrics (TTM)

Gross Margin

62.61%

Operating Margin

-35.20%

Net Income Margin

-47.43%

Return on Equity

-49.17%

Return on Capital

-21.57%

Return on Assets

-44.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

12.14K

Avg. Volume

32.79K

Financials (TTM)

Gross Profit

$89.25M

Operating Income

-$50.18M

EBITDA

-$62.52M

Operating Cash Flow

-$49.39M

Capital Expenditure

$15.25M

Free Cash Flow

-$34.14M

Cash & ST Invst.

$109.39M

Total Debt

$682.00K

Prenetics Global Performance Analysis

Prenetics Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3033.2%
Q42025-12-3155.2%
Q12026-03-31-1.7%
Q22026-06-3029.3%
Prenetics Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3043.6%
Q42025-12-31-230.2%
Q12026-03-3122.3%
Q22026-06-3061.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$46.49M

+162.9%

Gross Profit

$30.20M

+314.4%

Gross Margin

64.97%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

98

N/A

Net Income

-$8.98M

+27.6%

EBITDA

-$21.73M

-99.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$109.39M

+294.8%

Total Debt

$682.00K

-73.5%

Accounts Receivable

$5.13M

-48.8%

Inventory

$13.99M

+225.6%

Long Term Debt

$144.00K

-86.3%

Short Term Debt

$538.00K

-64.7%

Return on Assets

-44.00%

N/A

Return on Invested Capital

-42.85%

N/A

Free Cash Flow

$0.00

N/A

Operating Cash Flow

-$15.45M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NUWENuwellis, Inc.
$0.62-7.35%
OCEAOcean Biomedical, Inc.
$0.00+0.00%
BACKIMAC Holdings, Inc.
$0.00+0.00%
NLSPNLS Pharmaceutics AG
$2.91-12.61%

Trending Stocks

Symbol / CompanyPricePrice Chg
CIFRCipher Digital
$11.34-12.77%
BMBLBumble
$5.95+56.58%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$37.42+0.62%
INTCIntel
$102.81+1.44%

Questions About PRENW

What is the current price of Prenetics Global?

Prenetics Global is trading at $0.01 per share.

What is the 52-week range for Prenetics Global?

Over the past 52 weeks, Prenetics Global has traded between $0.01 and $0.04.

How much debt does Prenetics Global have?

Prenetics Global total debt is unavailable.

How much cash does Prenetics Global have on hand?

Prenetics Global does not have cash on hand data available.

What is Prenetics Global’s dividend yield?

Prenetics Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.